Hence, in the present study, we investigated the potential of ESR1, ESR2, and PGR as predictive and prognostic biomarkers in multiple cancer types from an immuno-oncological perspective based on bioinformatics analysis to provide a reference for future studies and the application of immunotherapies. This evidence concerns the gene PGR and cancer.